Worldcrunch on MSN37m
Lecanemab: Why This Could Be The Beginning Of The End Of Alzheimer’s
The first drug targeting the root cause of Alzheimer’s disease has been approved by the European Medicines Agency. Despite ...
The Pharma Letter56m
EMA/CHMP November recommendations include Leqembi U-turn
The European Medicines Agency’s (EMA) human medicines committee (CHMP) made a number of recommendations at its November ...
LkldNow on MSN44m
Lakeland Resident Finds New Hope at Walk to End Alzheimer’s
F or the last eight years, Lakeland resident Natalie Aviles has participated in Walk to End Alzheimer’s Polk County. Each year brings new motivation that, one day, her friends, ...